5 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Evaluation of the Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary DiseaseChronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorderRecruitingPhase 32026-09-28NCT07464587
Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemotherapy for the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma.Neoplasms by Histologic Type, adenocarcinoma, carcinoma, epithelial neoplasm, neoplasmRecruitingPhase 32026-06-25NCT07385703
A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast CancerHER2-positive Breast CancerRecruitingPhase 32026-03-27NCT07043725
Clinical Trial of TQC2731 Injection in Patients With Chronic Sinusitis and Nasal PolypsChronic Rhinosinusitis With Nasal Polyps (CRSwNP)RecruitingPhase 32025-12-16NCT07107256
Evaluation of the Clinical Trial of Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary DiseaseChronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorderNot yet recruitingPhase 32025-09-10NCT07147946